Skip to main content
. 2019 Jan 7;11(1):22. doi: 10.3390/toxins11010022

Table 2.

Clinical characteristics and comorbidities of Bothrops snakebite patients obtained on admission.

Variable Number %
Local manifestations (n = 412; 100%)
Pain 385 93.9
Swelling 382 93.4
Bleeding from fang punctures 120 29.3
Redness 120 29.1
Ecchymosis 36 8.7
Paresthesia 35 8.5
Haematoma 8 1.9
Blistering 7 1.7
Regional lymphadenopathy 4 1.0
Systemic alterations related to hemostasis
Unclottable blood (n = 386; 93.69%) 224 58.2
Bleeding (n = 412; 100%) 52 12.6
Trombocytopenia (n = 379; 91.99%) 33 8.7
Other systemic manifestations (n = 412; 100%)
Headache 47 11.4
Nausea 44 10.7
Vomiting 40 9.7
Blurred vision 14 3.4
Abdominal pain 7 1.7
Diarrhoea 5 1.2
Clinical severity of envenomation (n = 404; 98.06%)
Mild 112 27.7
Moderate 219 54.2
Severe 73 18.1
Comorbidities (n = 313; 75.97%)
Arterial hypertension 29 9.3
Diabetes 8 2.6
Hepatopathy 4 1.3
Cardiopathy 3 1.0
HIV/Aids 1 0.3
Time spent in hospital (days)
Mean (range) (n = 405, 98.30%) 7 (1–41)
Outcome (n = 411; 99.76%)
Discharged 411 100.0